Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis

J Antimicrob Chemother. 2023 Nov 6;78(11):2776-2778. doi: 10.1093/jac/dkad277.

Authors

Elisa Funiciello¹, Jacopo Mula², Federica Mignone¹, Erika Silvestro¹, Paola Ragazzi³, Giulia Pilloni³, Cristina Costa⁴, Antonio D'Avolio², Silvia Garazzino¹

Affiliations

¹ Paediatric Infectious Disease Unit, Regina Margherita Children's Hospital, University of Turin, Turin, Italy.
² Laboratory of Clinical Pharmacology and Pharmacogenetics, Amedeo di Savoia Hospital, Turin, Italy.
³ Paediatric Neurosurgery Unit, Regina Margherita Children's Hospital, University of Turin, Turin, Italy.
⁴ Microbiology Unit, Molinette Hospital, University of Turin, Turin, Italy.

PMID: 37671818
DOI: 10.1093/jac/dkad277

No abstract available

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Cefiderocol
Cephalosporins*
Drug Resistance, Multiple, Bacterial
Humans
Infant
Microbial Sensitivity Tests
Pseudomonas aeruginosa*

Substances

Cephalosporins
Anti-Bacterial Agents